CN115521266A - A kind of preparation method of vinyl isoxazolidine derivative - Google Patents
A kind of preparation method of vinyl isoxazolidine derivative Download PDFInfo
- Publication number
- CN115521266A CN115521266A CN202211315700.0A CN202211315700A CN115521266A CN 115521266 A CN115521266 A CN 115521266A CN 202211315700 A CN202211315700 A CN 202211315700A CN 115521266 A CN115521266 A CN 115521266A
- Authority
- CN
- China
- Prior art keywords
- copper
- vinyl
- oxime ether
- ether compound
- isoxazolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
技术领域technical field
本发明涉及有机化学合成技术领域,具体为一种乙烯基异噁唑烷衍生物的制备方法。The invention relates to the technical field of organic chemical synthesis, in particular to a preparation method of vinyl isoxazolidine derivatives.
背景技术Background technique
异噁唑环类化合物作为核苷、碳水化合物、PNA、氨基酸和类固醇类似物的模拟物,以及其抗癌,抗肿瘤,抗菌,抑制细胞周期分裂蛋白25(Cdc25A/Cdc25B)酶和含SH2结构域蛋白酪氨酸磷酸酶1(SHP-1)等广泛的生物活性而倍受关注。研究表明,将几个不同官能团或者分子骨架引入到某些分子中就行修饰,可改善母体分子生物活性,以便寻找高活性医药前体化合物。近年来,人们对异噁唑烷和含有异噁唑烷环的化合物的研究越来越多,涉及异噁唑烷环的新型化合物及其反应已被用于实现全合成或获得具有生物活性的化合物。Isoxazole rings as mimetics of nucleoside, carbohydrate, PNA, amino acid and steroid analogues, as well as their anticancer, antitumor, antibacterial, inhibitory cell cycle cleavage protein 25 (Cdc25A/Cdc25B) enzymes and SH2-containing structures domain protein tyrosine phosphatase 1 (SHP-1) has attracted much attention due to its wide range of biological activities. Studies have shown that introducing several different functional groups or molecular skeletons into certain molecules for modification can improve the biological activity of the parent molecule in order to find highly active pharmaceutical precursor compounds. In recent years, there have been more and more studies on isoxazolidines and compounds containing isoxazolidine rings, and new compounds involving isoxazolidine rings and their reactions have been used to achieve total synthesis or obtain biologically active compounds. compound.
本发明以异噁唑烷为分子骨架,引入乙烯基得到一种新型的2-乙烯基异噁唑烷衍生物,并通过铜催化的方法合成得到多种类型2-乙烯基异噁唑烷衍生物,丰富异噁唑环类化合物库。The present invention takes isoxazolidine as the molecular skeleton, introduces vinyl to obtain a new type of 2-vinyl isoxazolidine derivatives, and synthesizes various types of 2-vinyl isoxazolidine derivatives through a copper-catalyzed method. and enrich the library of isoxazole ring compounds.
发明内容Contents of the invention
本发明的目的在于提供一种乙烯基异噁唑烷衍生物的制备方法,制备方法简单,且可以通过优化反应条件达到反应条件温和,产率高、纯度高的效果。The purpose of the present invention is to provide a preparation method of vinyl isoxazolidine derivatives, the preparation method is simple, and the effects of mild reaction conditions, high yield and high purity can be achieved by optimizing the reaction conditions.
本发明的目的可以通过以下技术方案实现:The purpose of the present invention can be achieved through the following technical solutions:
一种乙烯基异噁唑烷衍生物的制备方法,包括如下步骤:有机溶剂在添加有铜催化剂和碱时,将O-丙炔基肟醚化合物与磺酰基叠氮搅拌反应,得到2-乙烯基异噁唑烷衍生物;O-丙炔基肟醚化合物的结构式为磺酰基叠氮的结构式为;2-乙烯基异噁唑烷衍生物的结构式为 A method for preparing vinyl isoxazolidine derivatives, comprising the following steps: when an organic solvent is added with a copper catalyst and a base, stirring and reacting an O-propynyl oxime ether compound with a sulfonyl azide to obtain 2-ethylene isoxazolidine derivatives; the structural formula of O-propynyl oxime ether compounds is The structural formula of sulfonyl azide is ; The structural formula of 2-vinyl isoxazolidine derivatives is
其中,O-丙炔基肟醚化合物、磺酰基叠氮和2-乙烯基异噁唑烷衍生物结构式中的R1、R2、R3独立地选自苯基、取代苯基、萘基、C1-C6烷基、C2-C6烯基、C1-C6烷氧基、卤素、卤代C1-C6烷基或卤代C1-C6烷氧基中的任意一种;Among them, R 1 , R 2 , and R 3 in the structural formulas of O-propynyl oxime ether compounds, sulfonyl azide and 2-vinyl isoxazolidine derivatives are independently selected from phenyl, substituted phenyl, naphthyl , C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 1 -C 6 alkoxy, halogen, halogenated C 1 -C 6 alkyl or halogenated C 1 -C 6 alkoxy any one;
所述铜催化剂为醋酸铜、氯化铜、溴化铜、乙酰丙酮铜、三氟乙酸铜、三氟甲磺酸铜、氧化铜、碘化亚铜、溴化亚铜、氯化亚铜、噻吩-2-甲酸铜、醋酸亚铜中的任意一种;Described copper catalyst is copper acetate, copper chloride, copper bromide, copper acetylacetonate, copper trifluoroacetate, copper trifluoromethanesulfonate, copper oxide, cuprous iodide, cuprous bromide, cuprous chloride, Any one of copper thiophene-2-carboxylate and cuprous acetate;
所述碱为三乙胺、正三丁胺、三叔丁胺、2-氟吡啶、2-氯吡啶、二异丙基乙胺、吡啶、2-甲基吡啶、氢氧化钠中的任意一种;The base is any one of triethylamine, n-tributylamine, tri-tert-butylamine, 2-fluoropyridine, 2-chloropyridine, diisopropylethylamine, pyridine, 2-picoline, sodium hydroxide;
所述有机溶剂为甲醇、乙醇、乙腈、四氢呋喃、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、氯苯、苯、二甲苯中的一种。The organic solvent is one of methanol, ethanol, acetonitrile, tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, chlorobenzene, benzene, and xylene.
作为本发明进一步的方案:所述O-丙炔基肟醚化合物、铜催化剂、碱的摩尔比为1:0.05-0.4:0.1-2;所述O-丙炔基肟醚化合物、磺酰基叠氮摩尔比为1:1-3。As a further solution of the present invention: the molar ratio of the O-propynyl oxime ether compound, copper catalyst, and base is 1:0.05-0.4:0.1-2; the O-propynyl oxime ether compound, sulfonyl alkene The nitrogen molar ratio is 1:1-3.
作为本发明进一步的方案:搅拌反应的温度为0-60℃且反应时间为0.5-8小时。As a further solution of the present invention: the stirring reaction temperature is 0-60° C. and the reaction time is 0.5-8 hours.
本发明的有益效果:Beneficial effects of the present invention:
本发明使用铜催化剂、使用胺类化合物作为碱,可由O-丙炔基肟醚化合物、磺酰基叠氮反应,一步得到2-乙烯基异噁唑烷衍生物,具有反应条件温和,产率高、纯度高、原子经济性高等诸多优点,为2-乙烯基异噁唑烷衍生物提供了全新路线和新思路,可在合成中间体、药物中间体、农药中间体等领域中发挥重要作用,在工业和科研上具有良好的应用价值和潜力。The present invention uses copper catalysts and amine compounds as bases to react O-propynyl oxime ether compounds and sulfonyl azide to obtain 2-vinylisoxazolidine derivatives in one step, with mild reaction conditions and high yield , high purity, high atom economy and many other advantages provide a new route and new ideas for 2-vinylisoxazolidine derivatives, which can play an important role in the fields of synthetic intermediates, pharmaceutical intermediates, pesticide intermediates, etc. It has good application value and potential in industry and scientific research.
附图说明Description of drawings
为了便于本领域技术人员理解,下面结合附图对本发明作进一步的说明。In order to facilitate the understanding of those skilled in the art, the present invention will be further described below in conjunction with the accompanying drawings.
图1为本发明O-丙炔基肟醚化合物与的磺酰基叠氮的反应机理图。Fig. 1 is the reaction mechanism diagram of O-propynyl oxime ether compound and sulfonyl azide of the present invention.
具体实施方式detailed description
下面将结合实施例对本发明的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。The technical solutions of the present invention will be clearly and completely described below in conjunction with the embodiments. Apparently, the described embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.
如图1所示,一种乙烯基异噁唑烷衍生物的制备方法,包括如下步骤:有机溶剂在添加有铜催化剂和碱时,将O-丙炔基肟醚化合物与磺酰基叠氮搅拌反应,得到2-乙烯基异噁唑烷衍生物;O-丙炔基肟醚化合物的结构式为磺酰基叠氮的结构式为;2-乙烯基异噁唑烷衍生物的结构式为 As shown in Figure 1, a kind of preparation method of vinyl isoxazolidine derivative, comprises the steps: when organic solvent is added with copper catalyst and alkali, O-propynyl oxime ether compound is stirred with sulfonyl azide Reaction, obtains 2-vinyl isoxazolidine derivative; The structural formula of O-propynyl oxime ether compound is The structural formula of sulfonyl azide is ; The structural formula of 2-vinyl isoxazolidine derivatives is
其中,O-丙炔基肟醚化合物、磺酰基叠氮和2-乙烯基异噁唑烷衍生物结构式中的R1、R2、R3独立地选自苯基、取代苯基、萘基、C1-C6烷基、C2-C6烯基、C1-C6烷氧基、卤素、卤代C1-C6烷基或卤代C1-C6烷氧基中的任意一种;Among them, R 1 , R 2 , and R 3 in the structural formulas of O-propynyl oxime ether compounds, sulfonyl azide and 2-vinyl isoxazolidine derivatives are independently selected from phenyl, substituted phenyl, naphthyl , C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 1 -C 6 alkoxy, halogen, halogenated C 1 -C 6 alkyl or halogenated C 1 -C 6 alkoxy any one;
铜催化剂为醋酸铜、氯化铜、溴化铜、乙酰丙酮铜、三氟乙酸铜、三氟甲磺酸铜、氧化铜、碘化亚铜、溴化亚铜、氯化亚铜、噻吩-2-甲酸铜、醋酸亚铜中的任意一种;The copper catalyst is copper acetate, copper chloride, copper bromide, copper acetylacetonate, copper trifluoroacetate, copper trifluoromethanesulfonate, copper oxide, cuprous iodide, cuprous bromide, cuprous chloride, thiophene- Any one of copper 2-formate and cuprous acetate;
碱为三乙胺、正三丁胺、三叔丁胺、2-氟吡啶、2-氯吡啶、二异丙基乙胺、吡啶、2-甲基吡啶、氢氧化钠中的任意一种;最优选为三乙胺;The base is any one of triethylamine, n-tributylamine, tri-tert-butylamine, 2-fluoropyridine, 2-chloropyridine, diisopropylethylamine, pyridine, 2-picoline, sodium hydroxide; most preferably triethylamine;
有机溶剂为甲醇、乙醇、乙腈、四氢呋喃、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、氯苯、苯、二甲苯中的一种;优选为乙腈;The organic solvent is one of methanol, ethanol, acetonitrile, tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, chlorobenzene, benzene, and xylene; preferably acetonitrile;
O-丙炔基肟醚化合物、铜催化剂、碱的摩尔比为1:0.05-0.4:0.1-2;O-丙炔基肟醚化合物、磺酰基叠氮摩尔比为1:1-3;The molar ratio of O-propynyl oxime ether compound, copper catalyst and base is 1:0.05-0.4:0.1-2; the molar ratio of O-propynyl oxime ether compound and sulfonyl azide is 1:1-3;
搅拌反应的温度为0-60℃且反应时间为0.5-8小时;The temperature of the stirring reaction is 0-60°C and the reaction time is 0.5-8 hours;
C1-C6烷基指具有1-6个碳原子的直链或支链烷基,其包括了C1烷基、C2烷基、C3烷基、C4烷基、C5烷基或C6烷基,可为甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、正戊基、异戊基或正己基等;C 1 -C 6 alkyl refers to straight chain or branched chain alkyl with 1-6 carbon atoms, which includes C 1 alkyl, C 2 alkyl, C 3 alkyl, C 4 alkyl, C 5 alkane Base or C 6 alkyl, which can be methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl or n-hexyl, etc. ;
C1-C6烷氧基是指C1-C6烷基与O原子相连后的基团;C 1 -C 6 alkoxy refers to the group after the C 1 -C 6 alkyl is connected to the O atom;
卤素的含义是指卤族元素,可为F、Cl、Br或I;The meaning of halogen refers to halogen elements, which can be F, Cl, Br or I;
卤代C1-C6烷基的含义是指被卤素取代的C1-C6烷基,可为三氟甲基、五氟乙基、二氟甲基、氯甲基等;The meaning of halogenated C 1 -C 6 alkyl refers to C 1 -C 6 alkyl substituted by halogen, which can be trifluoromethyl, pentafluoroethyl, difluoromethyl, chloromethyl, etc.;
卤代C1-C6烷氧基的含义是指被卤素取代的C1-C6烷氧基,可为三氟甲氧基、五氟乙氧基、二氟甲氧基、氯甲氧基等;The meaning of halogenated C 1 -C 6 alkoxy refers to C 1 -C 6 alkoxy substituted by halogen, which can be trifluoromethoxy, pentafluoroethoxy, difluoromethoxy, chloromethoxy Base etc.;
制备步骤具体是:将O-丙炔基肟醚化合物与磺酰基叠氮混合进行反应,在反应过程中,首先磺酰基叠氮与端炔化合物发生1,3-偶极环加成反应得到三氮唑复合物,接着发生开环重排,再与O-丙炔基肟醚化合物发生分子内的亲核加成、异构化得到2-乙烯基异噁唑烷衍生物;The preparation steps are as follows: mix the O-propynyl oxime ether compound with the sulfonyl azide for reaction, and in the reaction process, firstly, the sulfonyl azide and the terminal alkyne compound undergo 1,3-dipolar cycloaddition reaction to obtain three Azole complex, followed by ring-opening rearrangement, and intramolecular nucleophilic addition and isomerization with O-propynyl oxime ether compound to obtain 2-vinylisoxazolidine derivatives;
反应在铜催化剂的催化和碱的作用下进行,在铜催化剂和碱作用下,O-丙炔基肟醚化合物与的磺酰基叠氮的反应机理如图1;Reaction is carried out under the catalysis of copper catalyst and the effect of alkali, and under the effect of copper catalyst and alkali, the reaction mechanism of O-propynyl oxime ether compound and the sulfonyl azide is shown in Figure 1;
首先在铜催化剂、碱的作用下O-丙炔基肟醚化合物与磺酰基叠氮发生1,3-偶极环加成得到铜的复合物三氮唑A,接着发生开环重排,得到烯酮亚胺中间体B,烯酮亚胺中间体B发生分子内的亲核进攻,同时碳氮双键发生异构,最后得到2-乙烯基异噁唑烷衍生物;First, under the action of copper catalyst and base, O-propynyl oxime ether compound and sulfonyl azide undergo 1,3-dipolar cycloaddition to obtain copper complex triazole A, followed by ring-opening rearrangement to obtain Enketimine intermediate B, enketimine intermediate B undergoes intramolecular nucleophilic attack, and at the same time, the carbon-nitrogen double bond undergoes isomerization, and finally 2-vinylisoxazolidine derivatives are obtained;
铜催化剂包括醋酸铜、氯化铜、溴化铜、乙酰丙酮铜、三氟乙酸铜、三氟甲磺酸铜、氧化铜、碘化亚铜、溴化亚铜、氯化亚铜、噻吩-2-甲酸铜、醋酸亚铜中的任意一种或多种,优选碘化亚铜或氯化亚铜,最优选为碘化亚铜;Copper catalysts include copper acetate, copper chloride, copper bromide, copper acetylacetonate, copper trifluoroacetate, copper triflate, copper oxide, cuprous iodide, cuprous bromide, cuprous chloride, thiophene- Any one or more of 2-copper formate and cuprous acetate, preferably cuprous iodide or cuprous chloride, most preferably cuprous iodide;
O-丙炔基肟醚化合物与铜催化剂的摩尔比为1:0.05-0.4;The mol ratio of O-propynyl oxime ether compound and copper catalyst is 1:0.05-0.4;
丙炔基肟醚化合物与碱的摩尔比为1:0.1-2;The molar ratio of propynyl oxime ether compound and base is 1:0.1-2;
O-丙炔基肟醚化合物与有机溶剂的比例为1mmol:5-15mL,例如1mmol:5mL、1mmol:8mL、1mmol:10mL、1mmol:12mL或1mmol:15mL;The ratio of O-propynyl oxime ether compound to organic solvent is 1mmol: 5-15mL, such as 1mmol: 5mL, 1mmol: 8mL, 1mmol: 10mL, 1mmol: 12mL or 1mmol: 15mL;
反应结束后还包括后处理步骤,后处理包括萃取、浓缩、结晶、重结晶、柱层色谱提纯中的任何一种处理手段或多种处理手段的组合;After the reaction is finished, a post-treatment step is also included, and the post-treatment includes extraction, concentration, crystallization, recrystallization, any one of treatment means or a combination of multiple treatment means in column chromatography purification;
作为一种例举性的后处理手段,例如可为:将反应体系冷却至室温,旋转蒸发仪蒸除溶剂,残留物过200-300目硅胶柱,以乙酸乙酯/石油醚为洗脱剂,其中乙酸乙酯与石油醚的体积比为1:5-15,从而得到2-乙烯基异噁唑烷衍生物目标产物;As an exemplary post-treatment method, for example, the reaction system is cooled to room temperature, the solvent is evaporated by a rotary evaporator, the residue is passed through a 200-300 mesh silica gel column, and ethyl acetate/petroleum ether is used as the eluent , wherein the volume ratio of ethyl acetate to petroleum ether is 1:5-15, thereby obtaining the target product of 2-vinyl isoxazolidine derivatives;
作为另一种例举性的后处理手段,例如可为:反应完全后,将反应体系自然冷却至室温,加入等体积比的乙酸乙酯和饱和食盐水的混合液,振荡萃取2-4次,收集有机层、干燥,旋转蒸发浓缩,得粗产物,将粗产物过200-300目硅胶柱色谱层析,以乙酸乙酯和石油醚混合液为洗脱剂,其中乙酸乙酯与石油醚的体积比1:5-10,从而得到2-乙烯基异噁唑烷衍生物目标产物。As another exemplary post-treatment method, for example, after the reaction is complete, cool the reaction system to room temperature naturally, add a mixture of ethyl acetate and saturated saline in an equal volume ratio, shake and extract for 2-4 times , collect the organic layer, dry, and concentrate by rotary evaporation to obtain a crude product, which is subjected to 200-300 mesh silica gel column chromatography, using ethyl acetate and petroleum ether mixture as eluent, wherein ethyl acetate and petroleum ether The volume ratio is 1:5-10, so as to obtain the target product of 2-vinyl isoxazolidine derivatives.
实施例1Example 1
向乙腈中加入O-丙炔基肟醚化合物和磺酰基叠氮、碘化亚铜、三乙胺,然后室温下搅拌密封反应4小时。Add O-propynyl oxime ether compound, sulfonyl azide, cuprous iodide, and triethylamine to acetonitrile, then stir and seal the reaction at room temperature for 4 hours.
其中,O-丙炔基肟醚化合物与碘化亚铜的摩尔比为1:0.10;O-丙炔基肟醚化合物与三乙胺的摩尔比为1∶1.0;0-丙炔基肟醚化合物化合物与磺酰基叠氮的摩尔比为1∶1.5;以及以毫摩尔计的O-丙炔基肟醚化合物化合物与以毫升计的乙腈的比为1∶5;Among them, the molar ratio of O-propynyl oxime ether compound to cuprous iodide is 1:0.10; the molar ratio of O-propynyl oxime ether compound to triethylamine is 1:1.0; O-propynyl oxime ether the molar ratio of compound to sulfonyl azide is 1:1.5; and the ratio of O-propynyl oxime ether compound in millimoles to acetonitrile in milliliters is 1:5;
反应结束后,将反应体系自然冷却至室温,旋转蒸发浓缩,得粗产物,将粗产物过300-400目硅胶柱色谱层析,以乙酸乙酯和石油醚混合液为洗脱剂,其中乙酸乙酯与石油醚的体积比1∶5,从而得到为浅黄色粘稠液体的目标产物2-乙烯基异噁唑烷衍生物,产率为92%,纯度为99.0%;After the reaction, the reaction system was naturally cooled to room temperature, and concentrated by rotary evaporation to obtain a crude product, which was subjected to 300-400 mesh silica gel column chromatography, using a mixture of ethyl acetate and petroleum ether as the eluent, wherein acetic acid The volume ratio of ethyl ester to sherwood oil is 1: 5, thereby obtaining the target product 2-vinylisoxazolidine derivative as light yellow viscous liquid, the yield is 92%, and the purity is 99.0%;
核磁共振:1HNMR(400MHz,氘代氯仿CDCl3)δ7.76(d,J=7.8Hz,1H),7.64-7.60(m,1H),7.56-7.54(m,2H),7.44-7.40(m,2H),7.27-7.17(m,5H),7.15-7.11(m,1H),7.02-7.03(m,1H),6.63(d,J=8.6Hz,1H),4.52(s,2H)。NMR: 1 HNMR (400MHz, deuterated chloroform CDCl 3 ) δ7.76 (d, J=7.8Hz, 1H), 7.64-7.60 (m, 1H), 7.56-7.54 (m, 2H), 7.44-7.40 ( m, 2H), 7.27-7.17(m, 5H), 7.15-7.11(m, 1H), 7.02-7.03(m, 1H), 6.63(d, J=8.6Hz, 1H), 4.52(s, 2H) .
13CNMR(400MHz,氘代氯仿CDCl3)δ7.59(d,J=8.4Hz,2H),7.31(s,5H),7.18(d,J=8.0Hz,2H),5.61(s,1H),5.51(s,1H),4.40(t,J=8.2Hz,2H),3.71(t,J=8.2Hz,2H),2.38(s,3H); 13 CNMR (400MHz, deuterated chloroform CDCl3) δ7.59(d, J=8.4Hz, 2H), 7.31(s, 5H), 7.18(d, J=8.0Hz, 2H), 5.61(s, 1H), 5.51(s, 1H), 4.40(t, J=8.2Hz, 2H), 3.71(t, J=8.2Hz, 2H), 2.38(s, 3H);
13C NMR(100MHz,CDCl3)δ160.4,142.6,140.7,139.6,134.1,129.3(2C),129.2,128.5(2C),126.6(2C),126.4(2C),112.4,67.4,34.6,21.6。 13 C NMR (100MHz, CDCl 3 ) δ160.4, 142.6, 140.7, 139.6, 134.1, 129.3(2C), 129.2, 128.5(2C), 126.6(2C), 126.4(2C), 112.4, 67.4, 34.6, 21.6 .
实施例2Example 2
向乙腈中加入O-丙炔基肟醚化合物和磺酰基叠氮、碘化亚铜、三乙胺,然后升温至30℃,并在该温度下搅拌密封反应6小时;Add O-propynyl oxime ether compound and sulfonyl azide, cuprous iodide, triethylamine to acetonitrile, then raise the temperature to 30°C, and stir and seal the reaction at this temperature for 6 hours;
其中,O-丙炔基肟醚化合物与碘化亚铜的摩尔比为1∶0.15;O-丙炔基肟醚化合物与三乙胺的摩尔比为1∶1.2;O-丙炔基肟醚化合物化合物与磺酰基叠氮的摩尔比为1∶1.2;以及以毫摩尔计的O-丙炔基肟醚化合物与以毫升计乙腈的比为1∶7;Among them, the molar ratio of O-propynyl oxime ether compound to cuprous iodide is 1:0.15; the molar ratio of O-propynyl oxime ether compound to triethylamine is 1:1.2; O-propynyl oxime ether compound the molar ratio of compound to sulfonyl azide is 1:1.2; and the ratio of O-propynyl oxime ether compound in millimoles to acetonitrile in milliliters is 1:7;
反应完全后,将反应体系自然冷却至室温,减压蒸馏除去溶剂得粗产物,将粗产物过200-300目硅胶柱色谱层析,以乙酸乙酯和石油醚混合液为洗脱剂,其中乙酸乙酯与石油醚的体积比1∶7,从而得到为黄色固体的目标产物2-乙烯基异噁唑烷衍生物,产率为88%,纯度为98.3%;After the reaction was complete, the reaction system was naturally cooled to room temperature, and the solvent was distilled off under reduced pressure to obtain a crude product. The crude product was subjected to 200-300 mesh silica gel column chromatography, using a mixture of ethyl acetate and petroleum ether as an eluent, wherein The volume ratio of ethyl acetate to petroleum ether is 1:7, thereby obtaining the target product 2-vinylisoxazolidine derivative as a yellow solid, with a yield of 88% and a purity of 98.3%;
熔点:129-156℃;Melting point: 129-156°C;
核磁共振:1HNMR(400MHz,氘代氯仿CDCl3)δ7.73-7.82(m,4H),7.47-7.53(m,2H),7.40(t,J=8.4Hz,3H),6.92(d,J=5.6Hz,2H),5.65(s,1H),5.56(s,1H),4.48(t,J=8.2Hz,2H),3.76(t,J=8.2Hz,2H),2.30(s,3H);NMR: 1 HNMR (400MHz, deuterated chloroform CDCl 3 ) δ7.73-7.82(m, 4H), 7.47-7.53(m, 2H), 7.40(t, J=8.4Hz, 3H), 6.92(d, J=5.6Hz, 2H), 5.65(s, 1H), 5.56(s, 1H), 4.48(t, J=8.2Hz, 2H), 3.76(t, J=8.2Hz, 2H), 2.30(s, 3H);
13C NMR(100MHz,CDCl3)δ160.1,142.5,141.1,139.4,133.6,133.1,131.7,129.1(2C),128.4,128.1,127.8,126.8,126.6,126.22(2C),126.18,124.2,111.8,67.5,34.6,21.5。 13 C NMR (100MHz, CDCl 3 ) δ160.1, 142.5, 141.1, 139.4, 133.6, 133.1, 131.7, 129.1 (2C), 128.4, 128.1, 127.8, 126.8, 126.6, 126.22 (2C), 126.18, 114.8, 1 , 67.5, 34.6, 21.5.
实施例3Example 3
向乙腈中,加入O-丙炔基肟醚化合物和磺酰基叠氮、碘化亚铜、三乙胺,然后升温至40℃,并在该温度下搅拌密封反应5小时;其中,O-丙炔基肟醚化合物与碘化亚铜的摩尔比为1∶0.2;O-丙炔基肟醚化合物与三乙胺的摩尔比为1∶1.0;O-丙炔基肟醚化合物与磺酰基叠氮的摩尔比为1∶1.5;以及以毫摩尔计的O-丙炔基肟醚化合物与以毫升计的乙腈的比为1∶9;Add O-propynyl oxime ether compound, sulfonyl azide, cuprous iodide, and triethylamine to acetonitrile, then raise the temperature to 40°C, and stir and seal the reaction at this temperature for 5 hours; The molar ratio of the alkynyl oxime ether compound to cuprous iodide is 1:0.2; the molar ratio of the O-propynyl oxime ether compound to triethylamine is 1:1.0; the O-propynyl oxime ether compound and the sulfonyl alkene The molar ratio of nitrogen is 1:1.5; and the ratio of O-propynyl oxime ether compound in millimoles to acetonitrile in milliliters is 1:9;
反应完全后,将反应体系自然冷却至室温,减压蒸馏除去溶剂得粗产物,将粗产物过200-300目硅胶柱色谱层析,以乙酸乙酯和石油醚混合液为洗脱剂,其中乙酸乙酯与石油醚的体积比1∶5,从而得到为浅黄色液体的目标产物2-乙烯基异噁唑烷衍生物,产率为85%,纯度为96.8%;After the reaction was complete, the reaction system was naturally cooled to room temperature, and the solvent was distilled off under reduced pressure to obtain a crude product. The crude product was subjected to 200-300 mesh silica gel column chromatography, using a mixture of ethyl acetate and petroleum ether as an eluent, wherein The volume ratio of ethyl acetate and petroleum ether is 1:5, thereby obtaining the target product 2-vinylisoxazolidine derivative as light yellow liquid, the yield is 85%, and the purity is 96.8%;
核磁共振:1HNMR(400MHz,氘代氯仿CDCl3)δ7.80(d,J=8.8Hz,2H),7.27(d,J=6.4Hz,2H),5.28(s,1H),4.80(s,1H),4.35(t,J=7.0Hz,2H),3.66(t,J=7.0Hz,2H),2.40(d,J=7.6Hz,5H),1.35-1.41(m,2H),1.16-1.26(m,4H),0.84(t,J=5.8Hz,3H);NMR: 1 HNMR (400MHz, deuterated chloroform CDCl 3 ) δ7.80(d, J=8.8Hz, 2H), 7.27(d, J=6.4Hz, 2H), 5.28(s, 1H), 4.80(s , 1H), 4.35(t, J=7.0Hz, 2H), 3.66(t, J=7.0Hz, 2H), 2.40(d, J=7.6Hz, 5H), 1.35-1.41(m, 2H), 1.16 -1.26(m, 4H), 0.84(t, J=5.8Hz, 3H);
13C NMR(100MHz,CDCl3)δ158.5,142.8,142.1,139.9,129.4(2C),126.6(2C),105.6,67.2,35.0,32.8,31.2,27.6,22.5,21.6,14.1。 13 C NMR (100 MHz, CDCl 3 ) δ 158.5, 142.8, 142.1, 139.9, 129.4 (2C), 126.6 (2C), 105.6, 67.2, 35.0, 32.8, 31.2, 27.6, 22.5, 21.6, 14.1.
将实施例1-3的铜催化剂碘化亚铜替换为相同摩尔量的其他铜催化剂,其他操作相同,得到的产物收率分别如下:铜催化剂为氯化亚铜,产物收率为91;铜催化剂为溴化铜,产物收率为82;铜催化剂为三氟甲磺酸铜,产物收率为65;The copper catalyst cuprous iodide of embodiment 1-3 is replaced with other copper catalysts of the same molar amount, and other operations are identical, and the product yield obtained is as follows respectively: copper catalyst is cuprous chloride, and product yield is 91; The catalyst is copper bromide, and the product yield is 82%; the copper catalyst is copper trifluoromethanesulfonate, and the product yield is 65%;
由此可见,在不同的铜催化剂催化下,均能得到相应的产物,总体上一价铜化合物的反应效果比二价的要好,且其中CuI对的催化效果最好。It can be seen that under the catalysis of different copper catalysts, the corresponding products can be obtained. Generally, the reaction effect of the monovalent copper compound is better than that of the divalent copper compound, and the catalytic effect of the CuI pair is the best.
将实施例1-3的碱三乙胺替换为相同摩尔量的其他碱,其他操作相同,得到的产物收率分别如下:碱为三乙胺,产物收率为92;碱为三叔丁胺,产物收率为90;碱为2-氟吡啶,产物收率为82;由此可见,在碱中,与三乙胺非常类似的三级胺反应效果也比较好,吡啶类的碱也能得到一定的产物,无机碱的产率则显著的降低。The base triethylamine of embodiment 1-3 is replaced with other bases of the same molar amount, and other operations are the same, and the product yields obtained are as follows respectively: the base is triethylamine, and the product yield is 92%; the base is tri-tert-butylamine, and the product yield The yield is 90; the base is 2-fluoropyridine, and the product yield is 82; it can be seen that in the base, the reaction effect of the tertiary amine very similar to triethylamine is also better, and the base of pyridines can also be obtained to a certain extent. The product, the productive rate of inorganic base then significantly reduces.
将实施例1-3的有机溶剂乙腈替换为相同体积的其他溶剂,其他操作相同,得到的产物收率分别如下:有机溶剂为MeOH,产物收率为痕量;有机溶剂为THF,产物收率为87;有机溶剂为DMF,产物收率为76;The organic solvent acetonitrile of Example 1-3 is replaced by other solvents of the same volume, and other operations are the same, and the product yields obtained are as follows: the organic solvent is MeOH, and the product yield is a trace amount; the organic solvent is THF, and the product yield is Be 87; Organic solvent is DMF, and product yield is 76;
由此可见,有机溶剂同样对最终结果有着一定的影响,其中乙腈具有最好的效果,THF次之,其他溶剂的产率都有大幅度的降低。It can be seen that organic solvents also have a certain impact on the final result, wherein acetonitrile has the best effect, followed by THF, and the yields of other solvents are greatly reduced.
综上所述,由上述所有实施例可明确看出,当采用本发明的方法时,能够使O-丙炔基肟醚化合物和磺酰基叠氮顺利发生反应,从而得到目标产物,且产率良好、后处理简单,这些效果的取得,依赖于多个因素如催化剂、配体、溶剂的综合协同作用。In summary, it can be clearly seen from all the above examples that when the method of the present invention is adopted, the O-propynyl oxime ether compound and the sulfonyl azide can be reacted smoothly, thereby obtaining the target product, and the yield Good, simple post-treatment, the achievement of these effects depends on the comprehensive synergy of multiple factors such as catalysts, ligands, and solvents.
以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实施例并没有详尽叙述所有的细节,也不限制该发明仅为所述的具体实施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。The preferred embodiments of the invention disclosed above are only to help illustrate the invention. The preferred embodiments are not exhaustive in all detail, nor are the inventions limited to specific embodiments described. Obviously, many modifications and variations can be made based on the contents of this specification. This description selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can well understand and utilize the present invention. The invention is to be limited only by the claims, along with their full scope and equivalents.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211315700.0A CN115521266A (en) | 2022-10-25 | 2022-10-25 | A kind of preparation method of vinyl isoxazolidine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211315700.0A CN115521266A (en) | 2022-10-25 | 2022-10-25 | A kind of preparation method of vinyl isoxazolidine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115521266A true CN115521266A (en) | 2022-12-27 |
Family
ID=84703351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211315700.0A Pending CN115521266A (en) | 2022-10-25 | 2022-10-25 | A kind of preparation method of vinyl isoxazolidine derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115521266A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733725A (en) * | 2001-04-19 | 2006-02-15 | 卫材株式会社 | Process for preparing 2-iminopyrrolidine derivatives |
CN113666883A (en) * | 2021-07-23 | 2021-11-19 | 华南理工大学 | Method for synthesizing 4-vinyl isoxazole derivative |
-
2022
- 2022-10-25 CN CN202211315700.0A patent/CN115521266A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1733725A (en) * | 2001-04-19 | 2006-02-15 | 卫材株式会社 | Process for preparing 2-iminopyrrolidine derivatives |
CN113666883A (en) * | 2021-07-23 | 2021-11-19 | 华南理工大学 | Method for synthesizing 4-vinyl isoxazole derivative |
Non-Patent Citations (3)
Title |
---|
DORIS CHEN ET AL: "Efforts to wa rd s Rh(II)-catalyze d N -alkoxyazomethine ylide generation: Disparate reactivities of O-tethered α-diazo keto and -β-ketoester oximes", TETRAHEDRON, vol. 76, pages 1 - 13 * |
KAROLA RU¨CK-BRAUN ET AL: "1,3-Dipolar cycloaddition on solid supports: nitrone approach towards isoxazolidines and isoxazolines and subsequent transformations", CHEMICAL SOCIETY REVIEWS, vol. 34, pages 507 - 516 * |
PINGAN ZHAI ET AL: "Hydrazones as Substrates in the Synthesis of Isoxazolidines via a KOH-Promoted One-Pot Three-Component Cycloaddition with Nitroso Compounds and Olefins", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 86, pages 17710 - 17721 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106928117B (en) | A kind of preparation method of deuterated aromatic organic compound | |
WO2023109968A2 (en) | Synthesis method for finerenone and intermediate thereof | |
CN110183378B (en) | Nicotinamide derivative and catalytic synthesis method thereof | |
CN107235923A (en) | The preparation method of the aryl quinokysalines derivative of one class 3 | |
CN113234015B (en) | 3-acyl dihydroquinoline derivative and preparation method and application thereof | |
CN113402476B (en) | Imine oxazine derivative and preparation method thereof | |
CN107082771B (en) | Bis-alpha-cyanoimine substituted isochroman compounds and synthesis method thereof | |
CN112679494B (en) | Preparation method of pyrazolo [1,5-a ] pyridine derivative | |
CN113200873B (en) | Ortho-position halogenated arylamine compound and synthesis method thereof | |
CN114163452A (en) | A kind of preparation method of 1,3-oxazino 1,3-oxazole derivatives | |
CN109651271B (en) | A kind of synthetic method of 3-tert-butyl-N-methylquinoxaline-2(1H)-one compound | |
Jiang et al. | Oxidative cascade cyclization of N-arylacrylamides with TMSN 3 | |
CN115521266A (en) | A kind of preparation method of vinyl isoxazolidine derivative | |
CN107513056B (en) | A kind of synthetic method of quinoline compound containing tetrahydrofuran group | |
CN107690427A (en) | Novel method for preparing enzalutamide | |
CN110483387A (en) | A kind of method of one pot process nicotimine amide derivatives | |
CN113845481B (en) | Synthesis method of 4, 4-dimethyl-4, 5-dihydropyridazin-3-one | |
CN113173877B (en) | Indole acetyl imino sulfone series compounds and preparation method thereof | |
CN112047879B (en) | Method for selectively synthesizing halogenated arylamine by copper catalysis | |
CN114163436A (en) | Diarylmethane derivative containing indolizine and preparation method and application thereof | |
CN113214162A (en) | Preparation method of benzimidazole derivative | |
CN113979918A (en) | A kind of C-3 five-membered spirocyclic indolone derivative containing all-carbon tetra-substituted alkene structure and its preparation and application | |
CN112645841A (en) | 2-fluorobenzonitrile derivative and preparation method and application thereof | |
CN107973830B (en) | Total synthesis method of neooxytocin | |
CN112442005B (en) | N-sulfonyl imine coumarin derivative and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221227 |
|
RJ01 | Rejection of invention patent application after publication |